Here is another good news/bad news column about the 112th Congress.

Alzheimer's is a disease without a cure; the number of people afflicted continues to rise, and it is time for bureaucrats in Washington to support brain science research in the hope of finding a cure.

In past nuclear cooperation agreements, the US has required nations to commit to not enriching uranium and opening nuclear sites to inspections. The Obama administration has just done away with the requirement. Congress needs oversight to combat this possibility of nuclear proliferation.

Congress must take action to reform the use of the filibuster, but a recent congressional hearing offered some hope as it was more than partisans just talking past one another.

Critics of the U.S. tort system often argue that the contingency fee system provides incentives for excessive litigation. Many of the criticisms and suggested policy reforms are based, however, on anecdotal evidence, rather than on systematic study of the contingency fee system. While capping contingency fees is still one...

The problem with the Senate is much less the rules than the broader culture, leading to more polarization, less comity, more ideological division, and less institutional identity.

The FDA should be required to disclose its reasons for rejecting a drug, and Congress should reaffirm the provisions of the FDA Modernization Act.

It is shocking that no leader has tried to ensure that Congress can function through a catastrophe, whether caused by terrorism or epidemic.